Literature DB >> 20192974

Serum procalcitonin, C-reactive protein and white blood cell levels following hypothermia after cardiac arrest: a retrospective cohort study.

Philipp Schuetz1, Barbara Affolter, Sabina Hunziker, Clemens Winterhalder, Michael Fischer, Gianmarco M Balestra, Patrick Hunziker, Stephan Marsch.   

Abstract

INTRODUCTION: The aim of this study was to investigate time course of procalcitonin (PCT), C-reactive protein (CRP) and white blood cell (WBC) levels in patients with therapeutic hypothermia after cardiac arrest.
METHODS: We retrospectively assessed laboratory and clinical data in a consecutive cohort of patients admitted to the medical intensive-care-unit of the University Hospital in Basel, Switzerland, in whom therapeutic hypothermia was induced because of cardiac arrest between December 2007 and January 2009. Infection was considered based on microbiological evidence (restricted definition) and/or clinical evidence of infection with prescription of antibiotics (extended definition).
RESULTS: From 34 included patients, 25 had respiratory tract infection based on the clinical judgment and in 18 microbiological cultures turned positive (restricted definition). PCT concentrations were highest on the first day after hypothermia and showed a steady decrease until day 7 without differences in patients with and without presumed infection. CRP concentrations increased to a peak level at days 3-4 followed by a steady decrease; CRP concentrations were higher in patients with clinical diagnosis of infection on day 4 (P = 0.02); and in patients with evidence of bacterial growth in cultures on days 4 and 5 (P = 0.01 and P = 0.006). WBC remained unchanged after hypothermia without differences between patients with and without infection.
CONCLUSION: High initial values of PCT and high peak levels after 3-4 days of CRP were found in patients with induction of hypothermia after cardiac arrest. This increase was unspecific and mirrors rather an inflammatory reaction than true underlying infection, limiting the diagnostic potential for early antibiotic stewardship in these patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20192974     DOI: 10.1111/j.1365-2362.2010.02259.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  21 in total

1.  Diagnostic use of serum procalcitonin levels in pulmonary aspiration syndromes.

Authors:  Ali A El-Solh; Hardik Vora; Paul R Knight; Jahan Porhomayon
Journal:  Crit Care Med       Date:  2011-06       Impact factor: 7.598

2.  New approaches to sepsis: molecular diagnostics and biomarkers.

Authors:  Konrad Reinhart; Michael Bauer; Niels C Riedemann; Christiane S Hartog
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

3.  Sepsis Biomarkers.

Authors:  Yachana Kataria; Daniel Remick
Journal:  Methods Mol Biol       Date:  2021

4.  Optimizing triage and hospitalization in adult general medical emergency patients: the triage project.

Authors:  Philipp Schuetz; Pierre Hausfater; Devendra Amin; Sebastian Haubitz; Lukas Fässler; Eva Grolimund; Alexander Kutz; Ursula Schild; Zeljka Caldara; Katharina Regez; Andriy Zhydkov; Timo Kahles; Krassen Nedeltchev; Stefanie von Felten; Sabina De Geest; Antoinette Conca; Petra Schäfer-Keller; Andreas Huber; Mario Bargetzi; Ulrich Buergi; Gabrielle Sauvin; Pasqualina Perrig-Chiello; Barbara Reutlinger; Beat Mueller
Journal:  BMC Emerg Med       Date:  2013-07-04

Review 5.  Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and future.

Authors:  Philipp Schuetz; Werner Albrich; Beat Mueller
Journal:  BMC Med       Date:  2011-09-22       Impact factor: 8.775

6.  Predictive value of procalcitonin decrease in patients with severe sepsis: a prospective observational study.

Authors:  Sari Karlsson; Milja Heikkinen; Ville Pettilä; Seija Alila; Sari Väisänen; Kari Pulkki; Elina Kolho; Esko Ruokonen
Journal:  Crit Care       Date:  2010-11-15       Impact factor: 9.097

7.  Hypothermia does not increase the risk of infection: a case control study.

Authors:  Marlijn Kamps; Laurens A Bisschops; Johannes G van der Hoeven; Cornelia W E Hoedemaekers
Journal:  Crit Care       Date:  2011-02-03       Impact factor: 9.097

8.  Assessment of procalcitonin to predict outcome in hypothermia-treated patients after cardiac arrest.

Authors:  Pascal Stammet; Yvan Devaux; Francisco Azuaje; Christophe Werer; Christiane Lorang; Georges Gilson; Martin Max
Journal:  Crit Care Res Pract       Date:  2011-10-26

9.  Acute phase proteins and white blood cell levels for prediction of infectious complications in status epilepticus.

Authors:  Raoul Sutter; Sarah Tschudin-Sutter; Leticia Grize; Andreas F Widmer; Stephan Marsch; Stephan Rüegg
Journal:  Crit Care       Date:  2011-11-18       Impact factor: 9.097

10.  The impact of tracheotomy on levels of procalcitonin in patients without sepsis: a prospective study.

Authors:  Xingui Dai; Chunlai Fu; Changfa Wang; Yeping Cai; Sheng'an Zhang; Wei Guo; Daibing Kuang
Journal:  Clinics (Sao Paulo)       Date:  2015-09       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.